Long-term viability and extensibility of an in situ regenerated canine aortic wall using hybrid warp-knitted fabric.

Biodegradable polymer Congenital cardiac surgery Extensibility Mechanical strength Surgical material Tissue regeneration

Journal

Interactive cardiovascular and thoracic surgery
ISSN: 1569-9285
Titre abrégé: Interact Cardiovasc Thorac Surg
Pays: England
ID NLM: 101158399

Informations de publication

Date de publication:
26 07 2021
Historique:
received: 04 12 2020
revised: 25 01 2021
accepted: 05 02 2021
pubmed: 22 4 2021
medline: 25 11 2021
entrez: 21 4 2021
Statut: ppublish

Résumé

Many surgical materials promoting tissue regeneration have been explored for use in paediatric cardiac surgery. The aim of this study is to evaluate the long-term viability and extensibility of the canine aortic wall regenerated using a novel synthetic hybrid fabric. The sheet is a warp-knitted fabric of biodegradable (poly-l-lactic acid) and non-biodegradable (polyethylene terephthalate) yarns coated with cross-linked gelatine. This material was implanted as a patch to fill an oval-shaped defect created in the canine descending aorta. The tissue samples were explanted after 12, 24 or 36 months (N = 3, 2, 2, respectively) for histological examination and biomechanical testing. There was no shrinkage, rupture or aneurysmal change after 24 months. The regenerated wall showed prototypical vascular healing without material degeneration, chronic inflammation, calcification or abnormal intimal overgrowth. Bridging tissue across the patch was well-formed and had expanded over time. The biodegradable yarns had completely degraded at 24 months after implantation, as scheduled, but the regenerated aortic wall demonstrated satisfactory levels of mechanical strength and extensibility in tensile strength tests. The sheet achieved good long-term viability and extensibility in the regenerated aortic wall. These findings suggest that it is a promising surgical material for repairing congenital heart defects. Further developments of the sheet are required, including clinical studies.

Identifiants

pubmed: 33880514
pii: 6242732
doi: 10.1093/icvts/ivab064
pmc: PMC8691562
doi:

Substances chimiques

Polyethylene Terephthalates 0
Gelatin 9000-70-8

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

165-172

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Références

Curr Treat Options Cardiovasc Med. 2017 Sep;19(9):71
pubmed: 28782083
J Thorac Cardiovasc Surg. 2010 Feb;139(2):431-6, 436.e1-2
pubmed: 20106404
J Thorac Cardiovasc Surg. 2017 Jun;153(6):1542-1550
pubmed: 28314534
Biomaterials. 2017 May;125:101-117
pubmed: 28253994
Ann Surg. 2008 Sep;248(3):370-7
pubmed: 18791357
Ann Thorac Surg. 2016 Oct;102(4):1387-90
pubmed: 27645948
Cardiovasc Pathol. 2019 Jan - Feb;38:31-38
pubmed: 30428421
Circulation. 2006 Jul 4;114(1 Suppl):I159-66
pubmed: 16820566
Eur J Cardiothorac Surg. 2018 Aug 1;54(2):318-327
pubmed: 29462268
Science. 1993 May 14;260(5110):920-6
pubmed: 8493529
Circulation. 2010 Nov 30;122(22):2288-300
pubmed: 20975003
Circ Res. 1962 May;10:778-81
pubmed: 13901540
J Mech Behav Biomed Mater. 2009 Jan;2(1):3-19
pubmed: 19627803
Tissue Eng. 2006 Nov;12(11):3075-83
pubmed: 17518623

Auteurs

Shintaro Nemoto (S)

Department of Thoracic and Cardiovascular Surgery, Osaka Medical College, Osaka, Japan.

Hayato Konishi (H)

Department of Thoracic and Cardiovascular Surgery, Osaka Medical College, Osaka, Japan.

Tatsuya Suzuki (T)

Department of Thoracic and Cardiovascular Surgery, Osaka Medical College, Osaka, Japan.

Ryo Shimada (R)

Department of Thoracic and Cardiovascular Surgery, Osaka Medical College, Osaka, Japan.

Takahiro Katsumata (T)

Department of Thoracic and Cardiovascular Surgery, Osaka Medical College, Osaka, Japan.

Satomi Osawa (S)

Toxicology Research Department, Teijin Institute for Bio-Medical Research, Teijin Pharma Limited, Tokyo, Japan.

Ayuko Yamaguchi (A)

Healthcare Business Development-Medical Device, Teijin Limited, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH